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With advancements in endourology, the management
of proximal ureter stones has changed profoundly.
Before the development of extracorporeal shock wave
lithotripsy (ESWL), open ureterolithotomy and fluoro-
scopic basket extraction were the only available treat-
ment options for proximal ureteral stones. Post 1980,
ESWL became the preferred treatment for both renal
and ureteral stones removal due to its minimal invasive
nature and was recommended as a first line therapy
[1]. Recently, with the introduction of a small-caliber
semi-rigid and flexible ureteroscopy, and the devel-
opment of laser lithotripsy, almost every stone in the
upper tract can be treated with retrograde uretero-
scopy by a skilled surgeon. However, the treatment of
large and impacted proximal ureteral stones remain
controversial. The failure of ESWL and ureteroscopic
lithotripsy treatments may require open surgery or
laparoscopic ureterolithotomy. Percutaneous nephro-
lithotomy was introduced as an alternative treatment
for large renal stones, and the percutaneous approach
for treatment of proximal ureteral stones has also
achieved some success [2,3]. Herein, we report our
experience with the antegrade percutaneous approach
for the management of large and impacted proximal
ureteral stones.
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The treatment for patients with large impacted proximal ureteral stone remains controversial.
Extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy are the most popular treat-
ment options due to their minimal invasive nature. However, percutaneous nephroscopic
ureterolithotripsy is still important. Between June 2004 and March 2006, a total of 24 patients
underwent percutaneous antegrade nephrostomy for the removal of large impacted proximal
ureteral stones of size > 15 mm. Combined ultrasonic and pneumatic lithotripters were used for
the stone fragmentation. Twenty-three (95.8%) of the 24 patients were stone-free after one session
of surgery. The mean operation time was 125.4 ± 49.5 minutes (range, 45–170 minutes) and the
mean postoperative hospital stay was 4.7 ± 2.0 days (range, 4–12 days). Among the 24 patients, six
experienced transient postoperative fever that could be controlled with appropriate antibiotics
and supportive treatment, and two had blood loss requiring blood transfusion. We suggest that
percutaneous nephroscopic ureterolithotripsy is a safe and efficient treatment option for the
removal of large impacted proximal ureteral stones.
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MATERIAL AND METHODS
Between June 2004 and March 2006, a total of 24
patients (17 men and seven women) underwent per-
cutaneous antegrade nephrostomy for the removal of
large impacted proximal ureteral stones at Kaohsiung
Municipal Hsiao-Kang Hospital. The criteria for the
treatment included: (i) radio-opaque upper ureteral
stone of 15 mm or more in diameter; (ii) located be-
tween the ureteropelvic junction and the upper border
of the L5 vertebral body; and (iii) intravenous pyelo-
gram (IVP) confirmed impaction of the stone show-
ing no visible contrast media below the calculus on
any IVP film. However, patients with the following
conditions were excluded from the study: (i) renal
insufficiency with creatinine > 3.5 mg/dL; (ii) history
of previous irradiation or pelvic surgery; and (iii) a
persistent S-shaped bend in the ureter above the cal-
culus on any IVP film or nephrostogram.
Nephrostomy tract puncture and dilatation were
performed on the day before surgery. Standard tech-
niques of puncture and creation of the tract were used.
A chiba needle puncture was made with injection of
contrast media under ultrasonic guidance to opacify
the calyceal system. The middle or lower posterior
calyx was chosen for puncture. Once the needle en-
tered the pelvicalyceal system, a core guide wire was
negotiated into the renal pelvis and across the pelvi-
ureteric junction into the ureter. The guide wire was
coiled into the renal pelvis so that it could not be
pulled out of the kidney accidentally. A high-pressure
balloon dilation catheter (BlueMax; Boston Scientific,
Natick, MA, USA) of 10 mm in diameter and 8 cm in
length was used to dilate the nephrostomy tract to 30F.
The patient was laid in prone position under 
general anesthesia and a 26F rigid nephroscope was
introduced through a 30F Amplatz sheath along the
guide wire. Once the proximal ureteral stone was 
visible, a Swiss LithoClast Master (EMS, Switzerland),
which is a combination of ultrasonic and pneumatic
lithotripter unit, was used to break the stone into 
fragments. The fragments were then removed. A 6F
semi-rigid ureteroscope was used in cases with stone
downward migration. A double-J catheter was inserted
where possible, and a nephrostomy tube was left in
place for a few days postoperatively.
Operative findings, operation time, postoperative
complications, and postoperative hospital stay were
analyzed. Stone clearance was evaluated using a plain
film of the kidney, ureter, and bladder taken on the
third postoperative day. Stone-free was defined as no
residual stone visible on the plain film.
RESULTS
The mean age of the patients was 48.2 ± 11.2 years
and the mean size of the stone was 20.1 ± 5.4 mm 
with a stone burden of 232.8 ± 113.2 mm2. The demo-
graphic and clinical characteristics of patients are
shown in Table 1. All stones could be reached and
treated through the nephrostomy tract. A combined
lithoclast and ultrasonic lithotripter unit was used for
all patients. The lithoclast probe produced larger stone
fragments, removed with graspers and the ultrasound
lithotripter produced smaller sandy fragments, aspi-
rated through the hollow ultrasound probe.
Twenty-three of 24 (95.8%) patients had complete
calculus clearance through one session of surgery.
One patient required ESWL for residual downward
migrated ureteral stone. The mean operation time was
115.4 ± 49.5 minutes (range, 45–170 minutes) and the
average postoperative hospital stay was 4.7 ± 2.0 days
(range, 4–12 days). Six patients experienced transient
postoperative fever, and all cases were controlled with
appropriate antibiotics and supportive treatment. Two
patients had blood loss requiring blood transfusion.
One patient experienced delayed renal hemorrhage due
to excessive working and thus super-selective trans-
arterial embolization of traumatic aneurysm was per-
formed for pararenal hematoma and massive blood
loss. No urinary tract perforation or adjacent organ
injury occurred during the procedures. The operation-
related complications are shown in Table 2. In 13
Table 1. Demographic and clinical characteristics of
patients*
Age (yr) 48.2 ± 11.2
Male/female 17/7
BUN (mg/dL) 14.47 ± 3.69
Creatinine (mg/dL) 1.23 ± 0.27
Stone laterality (right/left) 14/10
Stone size (mm) 20.1 ± 5.4
Stone surface area (mm2) 232.8 ± 113.2
Associated renal stone (%) 10 (41.6)
Operation time (min) 115.4 ± 49.5
Postoperative hospital stay (d) 4.7 ± 2.0
*Data are presented as mean ± standard deviation or number
of patients. BUN = blood, urea, nitrogen.
patients with available stone analysis data, calcium
oxalate monohydrate with carbonate apatite was
found in 10 patients, carbonate apatite in two, and
carbonate oxalate dihydrate in one. Stone composi-
tion did not influence the efficiency of fragmentation,
operation time, or operation-related complications.
DISCUSSION
Since the development of ESWL and the advent of the
small caliber ureteroscope, ureteroscopic lithotripsy
(URSL) and ESWL have become the predominant
methods for treating ureteral stones. Although ESWL
is a safe and effective treatment for ureteral stones,
this modality has its limitations. ESWL does not suc-
cessfully break cystine stones, as these are harder than
others and ESWL usually splits rather than fragments
them [4,5]. Large stones may require several sessions
of ESWL treatment. For a proximal ureteral stone of
size < 10 mm, the stone-free rate for ESWL mono-
therapy was 69.3% and for size >10 mm, the stone-free
rate dropped to 59% [6]. Park et al [7] also reported
that, regardless of the stone size, after a single session
of ESWL for proximal ureteral stone, the stone-free rate
was 72.4% (size < 1.0 cm) and 42.1% (size > 1.0 cm).
The size of the stones was the most important factor
influencing the success rate of ESWL treatment [6–8].
With the development of smaller and more flexible
ureteroscopes, URSL became another choice for the
treatment of proximal ureteral stones [9]. The advan-
tage of URSL was immediate decompression of the
ureteral obstruction. However, for the treatment of
large impacted proximal ureteral stones, the stone
clearance rate was highly dependent on the experience
of the surgeon, with possible problems being failure
to approach the stone due to a tortuous ureter and
the stone migrating upwards into the kidney during
the procedure [8,10,11]. The stone-free rate for proxi-
mal ureteral stones of size > 15 mm after one session
of URSL ranged widely from 35% to 87% [8,11].
Despite the advances of ESWL and ureteroscope
with holmium:yttrium-aluminum-garnet (Ho:YAG)
laser lithotripsy, the percutaneous approach for
removal of ureteral stone continues to be important.
The advantages of percutaneous nephroscopic uretero-
lithotripsy include: first, most impacted proximal
ureteral stones are combined with edematous and
polypoid ureter wall, which need more skill for the
surgeon to remove the stone with retrograde
ureteroscopy [10]. The dilated ureter and renal pelvis
proximal to the stone offer more space for nephro-
scopic manipulation. Second, almost all developed
lithotripter probes can be used during percutaneous
nephroscopic ureterolithotripsy, including electrohy-
draulic lithotripter, pneumatic lithotripter, ultrasonic
lithotripter, and Ho:YAG laser lithotripter. Compared
with the standard ultrasonic device, the combination
instrument could disintegrate and remove stones
almost twice as rapidly [12]. Third, percutaneous
nephroscopic ureterolithotripsy has the advantage in
that any associated renal stone could be removed
simultaneously [13]. In our series, 10 (41.6%) patients
had combined renal stones, and in all but one both
the renal and ureteral stones were removed simulta-
neously in one session of operation. Percutaneous
nephroscopic ureterolithotripsy could achieve a total
stone-free rate of 86–98.5% for stone size > 15 mm
[1,13], which is superior to any other treatment. In
this study, the stone-free rate was 95.8% after at least
3 months of follow-up.
With recent advances in laparoscopic techniques,
many urologic surgeries, including ureterolithotomy
can be managed with the aid of a laparoscope. Recent
series from various centers showed that both retroperi-
toneal and transperitoneal approaches were feasible and
safe [14]. Laparoscopic ureterolithotomy can achieve as
high a success rate for large proximal ureteral stones
as percutaneous nephroscopic ureterolithotripsy [15].
However, the long-standing impacted ureteral stones
are usually accompanied by severe adhesion around
the stone, increasing the difficulty of ureter identifi-
cation and stone removal. The operative complication
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Table 2. Operative findings and operation-related com-
plications in the 24 patients
Patients, n (%)
Operative findings
Ureteral stenosis 7 (29.1)
Ureteral polyp 15 (62.5)
Postoperative complications
Fever 6 (25)
Significant blood loss 2 (8.3)
Perforation 0
Sepsis 0
Double-J catheter stenting 18 (66.7)
Stone-free 23 (95.8)
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most encountered in laparoscopic ureterolithotomy
is urinary leakage, which is due to inflammatory local
conditions and incomplete ureter closure [14,16]. The
role of laparoscopic ureterolithotomy remains as a
salvage procedure for failed ESWL or ureteroscopy
and an alternative therapy to open ureterolithotomy.
The complications of percutaneous nephroscopic
ureterolithotripsy are similar to those of percuta-
neous nephrolithotomy [13,17]. Bleeding is the main
complication and fever is the most encountered com-
plication [17]. During the procedure, bleeding from the
renal parenchyma occurred due to the extremely vas-
cular nature of the kidney. In most cases, bleeding can
be managed conservatively, but about 2–5% of patients
may require a blood transfusion and very rarely arte-
rial embolization may be required [18]. In our series,
delayed postoperative hemorrhage occurred in one
patient 3 months after operation. Super-selective arte-
rial embolization of the bleeding intrarenal vessel
was performed. Infection, fever, or urosepsis are mini-
mized by routine prophylaxis with broad-spectrum
intravenous antibiotics. The incidence of transient
fever was 25% in the present series and all cases
could be managed conservatively with appropriate
antibiotics, fluid supply, and bed rest. No patient
experienced severe sepsis. Perforation of the collect-
ing system is seen but major perforation is unusual.
Most occur after advancement of dilators or sheath.
Damage to various organs including liver, spleen,
duodenum, or colon is reported in < 1% of cases 
[19]. There were no injuries to surrounding organs or
pneumothorax in our patients. We believe that this
could be attributed to the appropriate puncture route
under ultrasonic and fluoroscopic guidance.
In conclusion, we suggest that percutaneous
nephroscopic ureterolithotomy remains a safe and
efficient treatment option for proximal ureter stone,
especially when the stone size is > 15 mm and the
stone is impacted in the proximal ureter.
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